A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab

NCT06513221 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University